Skip to main content Accessibility help
×
Hostname: page-component-77f85d65b8-6c7dr Total loading time: 0 Render date: 2026-04-21T17:41:58.836Z Has data issue: false hasContentIssue false

3 - Clinical recognition

Published online by Cambridge University Press:  31 July 2009

Golder N. Wilson
Affiliation:
Department of Pediatrics, Texas Tech University
E. Steve Roach
Affiliation:
Wake Forest University, North Carolina
Van S. Miller
Affiliation:
University of Texas Southwestern Medical Center, Dallas
Get access

Summary

Introduction

Equally powerful for generalists or specialists, with simple principles available for every field of medicine, genetics is fundamental to diagnosis and prevention. Neurocutaneous syndromes illustrate the value of the genetic approach, since they often exhibit Mendelian inheritance. They also illustrate the value of pattern recognition, since the association of congenital brain and skin anomalies often predicts a broad spectrum of disease. This chapter presents basic principles of genetics and dysmorphology, illustrating the use of these principles in approaching the spectrum of neurocutaneous diseases.

Key to the genetic approach are resources that provide information on rare diseases. Paramount among these is the catalogue of genetic diseases originally assembled by Victor McKusick (Online Mendelian Inheritance in Man, 2002). Each disease thought to exhibit Mendelian inheritance and, more recently, each characterized human gene or protein has been assigned a 6-digit number. McKusick numbers will be provided for the genetic and neurocutaneous diseases mentioned in this chapter, allowing easy reference at the on-line website. Management of the more common disorders is discussed by Wilson & Cooley (2000).

The genetic approach in medicine

While individual genetic disorders may be rare, the effect of genetic factors on disease is widespread. Coronary artery disease is an example where a focus on extreme disease (young people with heart attacks) identified a gene involved in cholesterol uptake. Once autosomal dominant hypercholesterolemia was characterized by mutations in the low density lipoprotein receptor, cholesterol testing became an indicator of genetic risk that led to diet or drug therapy.

Information

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Clinical recognition
  • Edited by E. Steve Roach, Wake Forest University, North Carolina, Van S. Miller, University of Texas Southwestern Medical Center, Dallas
  • Book: Neurocutaneous Disorders
  • Online publication: 31 July 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545054.005
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Clinical recognition
  • Edited by E. Steve Roach, Wake Forest University, North Carolina, Van S. Miller, University of Texas Southwestern Medical Center, Dallas
  • Book: Neurocutaneous Disorders
  • Online publication: 31 July 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545054.005
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Clinical recognition
  • Edited by E. Steve Roach, Wake Forest University, North Carolina, Van S. Miller, University of Texas Southwestern Medical Center, Dallas
  • Book: Neurocutaneous Disorders
  • Online publication: 31 July 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545054.005
Available formats
×